HEALTH CARE:
PHARMACEUTICALS
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Amgen Inc. (Amgen) is an independent biotechnology medicines company. The Company discovers, develops, manufactures and markets medicines for grievous illnesses. It focuses on human therapeutics and concentrates on medicines based on advances in cellular and molecular biology. Its principal products include Aranesp (darbepoetin alfa) and EPOGEN (Epoetin alfa), erythropoietic-stimulating agents (ESAs) that stimulate the production of red blood cells; Neulasta (pegfilgrastim), a pegylated protein, based on the Filgrastim molecule, and NEUPOGEN (Filgrastim), a recombinant-methionyl human granulocyte colony-stimulating factor (G-CSF), both of which selectively stimulate the production of neutrophils (a type of white blood cell that helps the body fight infection), and Enbrel (etanercept), an inhibitor of tumor necrosis factor (TNF), a substance that plays a role in the body's response to inflammatory diseases.
| Market Cap | 122.113 Billion | Shares Outstanding | 725.91 Million | Avg Volume | 5.617 Million |
| 1-Yr BETA vs S&P TR | Current Ratio | 5.49 | Quick Ratio | 5.17 |
| Q3 2018 | All Institutions | Hedge Funds 1 |
|---|---|---|
| To trade AMGN now: | |
|
| Filers who had this stock in their top 10: | 103 | 14 (1.35%) |
| 13F Filers holding this stock: | 1744 | 124 (11.97%) |
| Aggregate 13F shares on 09/30/2018: | 489.579 Million | 21.263 Million |
| Aggregate 13F shares on 06/30/2018: | 535.438 Million | 20.006 Million |
| Percent change: | -8.56% | 6.28% |
| Funds creating new positions: | 106 | 17 |
| Funds Adding to an existing position: | 592 | 41 |
| Funds closing out their position: | 66 | 16 |
| Funds reducing their position: | 775 | 52 |
| Heat Map Ranking for 09/30/2018 | 5 | |
| Heat Map Ranking for 06/30/2018 | 81 | |
| 1 hedge funds as identified by whalewisdom.com through public filings. | ||
View recent insider trading info
Please sign in first
none
1.8 Thousand total shares from 1 transactions
8.3 Thousand total shares from 2 transactions
| Reporting Owners | Transaction Date | Transaction Code | Shares | Acquired or Disposed | Shares Owned Following Transaction | Direct/Indirect Ownership |
|---|---|---|---|---|---|---|
| 2018-11-30 | M | 6,500 | a | 45,128 | direct | |
| 2018-11-30 | M | 6,500 | d | 0 | direct | |
| 2018-11-30 | F | 4,109 | d | 41,019 | direct | |
| 2018-11-29 | M | 1,777 | a | 23,090 | direct | |
| 2018-11-29 | M | 1,777 | d | 0 | direct | |
| 2018-11-29 | S | 1,777 | d | 21,313 | direct | |
| 2018-11-05 | A | 93 | a | 1,427 | direct | |
| 2018-11-02 | A | 34,213 | a | 34,213 | direct | |
| 2018-11-02 | A | 149 | a | 3,312 | direct | |
| 2018-11-02 | A | 12,830 | a | 30,618 | direct |
